0003-0371 : Nulojix 250 mg/1 Intravenous Injection, Powder, Lyophilized, for Solution


NDC: 0003-0371
Labeler: E.r. Squibb & Sons, L.L.C.
Product Type: Human Prescription Drug
Drug Name:  Nulojix
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: BLA125288
Rev. Date: 


NDC Package Codes:

  • 0003-0371-13: 1 VIAL, SINGLE‑USE IN 1 CARTON (0003‑0371‑13) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL, SINGLE‑USE

Active Ingredients:

  • Belatacept

Dosage Strength:

  • 250 mg

Pharmaceutical Classes:

  • T Lymphocyte Costimulation Activity Blockade [PE]
  • Selective T Cell Costimulation Blocker [EPC]
  • CD80-directed Antibody Interactions [MoA]
  • CD86-directed Antibody Interactions [MoA]

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0003-0371 QR Code

< Prev: 0003-0315Next: 0003-0494 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.